Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings.
about
Developments in CD4 and viral load monitoring in resource-limited settingsCD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapyEvaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapyHow to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South AfricaDiagnostic point-of-care tests in resource-limited settingsWHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients.The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.Multisite evaluation of point of care CD4 testing in Papua New GuineaEvaluation of PIMA™® point of care technology for CD4 T cell enumeration in Kenya.CD4 T-cell enumeration in a field setting: evaluation of CyFlow counter using the CD4 easy count kit-dry and Pima CD4 systemsFeasibility of performing multiple point of care testing for HIV anti-retroviral treatment initiation and monitoring from multiple or single fingersticksLaboratory and field evaluation of the Partec CyFlow miniPOC for absolute and relative CD4 T-cell enumerationField Evaluation of a Point-of-Care CD4 Analyzer for Monitoring HIV Patients in the Interior of the Amazon Region, Brazil.A meta-analysis of the performance of the Pima™ CD4 for point of care testing.Low-cost assays for monitoring HIV infected individuals in resource-limited settings.Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South AfricaThe HIV Care Continuum among Female Sex Workers: A Key Population in Lilongwe, MalawiPerspectives on introduction and implementation of new point-of-care diagnostic testsEvaluation of PIMATM CD4 System for Decentralization of Immunological Monitoring of HIV-Infected Patients in Senegal.Errors generated by a point-of-care CD4+ T-lymphocyte analyser: a retrospective observational study in nine countriesClinical Evaluation of the BD FACSPresto™ Near-Patient CD4 Counter in KenyaPerformance of FACSPresto Point-of-Care Instrument for CD4-T Cell Enumeration in Human Immunodeficiency Virus (HIV)-Infected Patients Attending Care and Treatment Clinics in Belgium and Tanzania.Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South AfricaUtility of the point of care CD4 analyzer, PIMA, to enumerate CD4 counts in the field settings in India."Can't you initiate me here?": Challenges to timely initiation on antiretroviral therapy among methadone clients in Dar es Salaam, Tanzania.Point-of-care testing for sexually transmitted infections: recent advances and implications for disease controlEvaluation of PIMA point-of-care CD4 analyzer in Yunnan, China.Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant womenTracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapySimplified clinical prediction scores to target viral load testing in adults with suspected first line treatment failure in Phnom Penh, Cambodia.PIMA Point of Care CD4+ Cell Count Machines in Remote MNCH Settings: Lessons Learned from Seven Districts in Zimbabwe.Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.Where are we at with point-of-care testing in haematology?Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries.Access and Quality of HIV-Related Point-of-Care Diagnostic Testing in Global Health Programs.CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients.CD4 Lymphocyte Enumeration and Hemoglobin Assessment Aid for Priority Decisions: A Multisite Evaluation of the BD FACSPresto™ System.PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa.Point of Care Diagnostics for HIV in Resource Limited Settings: An OverviewEvaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube
P2860
Q26860854-488B57B6-2804-4208-B580-675C453BF7E2Q26864454-45DF7D6D-743E-41F4-8355-B279A5E65F62Q28730448-A233EFB9-52C1-4C3D-9205-AE6DBEC2B7A0Q28730481-EAFEB33C-2CAD-4106-ABDB-87DD2FB43701Q33590492-6463499F-0AAF-4236-B68F-6C35977C18C6Q34110875-03420433-16E0-4BD6-8CCC-E8BFE1BC26C1Q34195493-C12964D4-329A-4FF7-BDB3-F8ADFCCBA6B9Q34575949-BEA660DE-7B13-43A6-BA47-C61CDD4404C6Q34795056-122FC8B0-F0F0-4BB6-A0C5-A933AE8038F6Q34997527-88550C85-5A52-45DA-8CFC-57237782E72AQ35078554-5F9998FA-4477-45AC-981A-A526A610F424Q35092430-3B704F03-357A-429F-A494-A9D7BC1F518BQ35533012-48FA3274-A361-4D1C-81D2-2FDBBF19E26DQ35712626-1BFEAF0A-2160-427E-A587-2E21903C52C5Q35770858-1F3D9732-0F08-4185-BC1C-DDD4E5537BAAQ35848080-CF0BF62A-47AB-4F35-861E-88E0F7745593Q35903309-C2694009-0614-408A-9C8B-C54746535F71Q35907400-81E8F2E3-2385-4918-A86A-5A2D8EDEF7A2Q36014143-3320BCEC-69EC-4F8B-97C3-12E3A721A389Q36089448-2B677EA9-CB21-4A76-883F-A2EE7D3F68AAQ36092410-7B78D5FD-3955-4C40-9510-6FB5C53E5F0EQ36262368-6BAE2822-3CEA-4BB5-9726-00D954BBAA38Q36279351-823369E5-6ACE-449A-8599-FA46C1EFE415Q36415997-FFDD051C-54CC-4E10-AA64-4BC57688425CQ36792064-C74BF53E-A6D0-4509-907E-FA5265A8ABF9Q36792243-F799EFC5-AE7F-4A4D-822C-A0DBFED4FC04Q36804868-E7619A08-C79E-46F3-9D7D-BEC590134481Q37180454-B244E591-938F-43E7-90C8-774F8AAB15F0Q37225313-320DB5C4-D9FB-4F6D-B449-12B945C254B9Q37554466-5C5BBFD3-38DE-485D-BB28-9980715EC8A5Q37705892-A407D102-5E04-436B-A30D-764127A152E9Q37965693-4B6826BB-FC14-4254-A1E4-A65DC1ED9625Q38024135-177AAA24-5B8A-4A2A-9500-91A9D9456938Q38059894-3FF12C32-3992-4B6C-8F39-617C249381A1Q38386355-972E87EE-39E1-411E-9F56-B570F0CAAECDQ38961200-68ACEA71-69C4-451C-A7B5-6151C5225118Q47095733-DC5C7250-CC26-4F95-ACE9-DF2369A7A93CQ53759790-74296C9C-B0BE-4D1B-825A-8BB8AA86F210Q57826025-CCA34050-1F66-4092-8702-98C8B9B2EE42Q58715673-F435C686-6C50-49A2-BEAE-0B69E1AA4D60
P2860
Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Performance evaluation of the ...... resource-constrained settings.
@en
Performance evaluation of the ...... resource-constrained settings.
@nl
type
label
Performance evaluation of the ...... resource-constrained settings.
@en
Performance evaluation of the ...... resource-constrained settings.
@nl
prefLabel
Performance evaluation of the ...... resource-constrained settings.
@en
Performance evaluation of the ...... resource-constrained settings.
@nl
P2093
P1476
Performance evaluation of the ...... resource-constrained settings
@en
P2093
Boonrat Tassaneetrithep
Charin Thepthai
Kasama Sukapirom
Korakot Polsrila
P304
P356
10.1097/QAI.0B013E31822866A2
P407
P577
2011-10-01T00:00:00Z